Karyopharm OK To Borrow $25M In Fast-Track Ch. 11 Case

By Alex Wittenberg · November 3, 2026, 8:30 PM EST

Cancer drug developer Karyopharm Therapeutics Inc. on Tuesday secured a Texas bankruptcy judge's approval to borrow $25 million in Chapter 11 financing and solicit bids for its business, as the company...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Karyopharm Therapeutics Inc.

Case Number

4:26-bk-90827

Court

Texas Southern

Nature of Suit

Date Filed

November 02, 2026